REVELATION BIOSCIENCES, INC. Accounts Payable
REVELATION BIOSCIENCES, INC. (REVB) had Accounts Payable of $931.09 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $931.09K.
- 2026-03-31: Accounts Payable, Current $828.20K.
- 2025-12-31: Accounts Payable, Current $577.50K.
- 2025-09-30: Accounts Payable, Current $1.03M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $931.09K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $828.20K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $577.50K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.03M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $828.89K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $625.06K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $783.62K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.13M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.28M 10-Q/A · filed 2024-09-23 | |
| 2024-03-31 | $1.68M 10-Q/A · filed 2024-09-23 | |
| 2023-12-31 | $1.36M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $913.87K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $705.09K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $554.21K 10-K/A · filed 2024-09-23 | |
| 2022-09-30 | $466.08K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $916.48K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.46M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $596.26K 10-K · filed 2023-03-30 | $784.80K 10-K · filed 2022-04-15 |
| 2021-09-30 | $310.53K 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $230.00K 10-Q · filed 2021-08-23 | |
| 2020-12-31 | $33.77K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |